| Literature DB >> 31334049 |
Hassan Al-Thani1, Gaby Jabbour1, Ayman El-Menyar2,3, Bianca M Wahlen4, Mohammad Asim2, Husham Abdelrahman1, Syed Nabir5, Hisham Al-Jogol1, Ismail Mahmood1, Ahmed El-Faramawy1, Ashok Parchani1, Ibrahim Afifi1, Ruben Peralta1.
Abstract
PURPOSE: We aimed to assess the pattern and impact of sternal injury with rib fracture in a Level 1 trauma center. PATIENTS AND METHODS: We conducted a retrospective review of trauma registry data to identify patients who presented with sternal fracture between 2010 and 2017. Data were analyzed and compared in patients with and without rib fracture.Entities:
Keywords: Clinical presentation; outcomes; rib fractures; sternal injury
Year: 2019 PMID: 31334049 PMCID: PMC6625325 DOI: 10.4103/IJCIIS.IJCIIS_67_18
Source DB: PubMed Journal: Int J Crit Illn Inj Sci ISSN: 2229-5151
STROBE statement: Checklist of items that should be included in reports of observational studies
| Section/Topic | Item number | Recommendation | Reported on page number |
|---|---|---|---|
| Title and abstract | 1 | Indicate the study’s design with a commonly used term in the title or the abstract | 1, 2 |
| Introduction | |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 3 |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | 4 |
| Methods | 4, 5 | ||
| Study design | 4 | Present key elements of study design early in the paper | 4 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | 4, 5 |
| Participants | 6 | (a) Cohort study - Give the eligibility criteria and the sources and methods of selection of participants. Describe methods of follow-up | 4, 5 |
| Case-control study - Give the eligibility criteria and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls | |||
| Cross-sectional study - Give the eligibility criteria and the sources and methods of selection of participants | |||
| (b) Cohort study - For matched studies, give matching criteria and number of exposed and unexposed | |||
| Case-control study - For matched studies, give matching criteria and the number of controls per case | |||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | 4,5 |
| Data sources/measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | |
| Bias | 9 | Describe any efforts to address potential sources of bias | |
| Study size | 10 | Explain how the study size was arrived at | |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | |
| Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding | |
| (b) Describe any methods used to examine subgroups and interactions | |||
| (c) Explain how missing data were addressed | |||
| (d) Cohort study - If applicable, explain how loss to follow-up was addressed | 5 | ||
| Case-control study - If applicable, explain how matching of cases and controls was addressed | |||
| Cross-sectional study - If applicable, describe analytical methods taking account of sampling strategy | |||
| (e) Describe any sensitivity analyses | |||
| Results | 5-7 | ||
| Participants | 13* | (a) Report numbers of individuals at each stage of study - e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed | |
| (b) Give reasons for nonparticipation at each stage | |||
| Descriptive data | 14* | (a) Give characteristics of study participants (e.g. demographic, clinical, and social) and information on exposures and potential confounders | |
| (b) Indicate number of participants with missing data for each variable of interest | |||
| (c) Cohort study - Summarize follow-up time (e.g., average and total amount) | |||
| Outcome data | 15* | Cohort study - Report numbers of outcome events or summary measures over time | |
| Case-control study - Report numbers in each exposure category or summary measures of exposure | |||
| Cross-sectional study - Report numbers of outcome events or summary measures | |||
| Main results | 16 | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% CI). Make clear which confounders were adjusted for and why they were included | |
| (b) Report category boundaries when continuous variables were categorized | |||
| Other analyses | 17 | Report other analyses done - e.g., analyses of subgroups and interactions and sensitivity analyses | |
| Discussion | 7-11 | ||
| Key results | 18 | Summarize key results with reference to study objectives | |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | |
| Generalizability | 21 | Discuss the generalizability (external validity) of the study results | |
| Other information | |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 13 |
http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org
Characteristics of sternal fracture patients sustained rib versus no rib fractures
| Overall ( | No rib fracture (44%) | With rib fracture (56%) | ||
|---|---|---|---|---|
| Age | 38.3±15.1 | 37.8±14.5 | 40.1±13.6 | 0.32 |
| Males, n (%) | 197 (92.9) | 86 (92.5) | 111 (93.3) | 0.82 |
| Mechanism of injury, n (%) | ||||
| Traffic accidents | 155 (73.1) | 66 (71.0) | 89 (74.8) | 0.04 for all |
| Fall from height | 34 (16.0) | 20 (21.5) | 14 (11.8) | |
| ATV crashes | 6 (2.8) | 3 (3.2) | 3 (2.5) | |
| Fall of heavy objects | 9 (4.2) | 1 (1.1) | 8 (6.7) | |
| Self-inflected | 2 (0.9) | 2 (2.2) | 0 (0.0) | |
| Others | 6 (2.8) | 1 (1.1) | 5 (4.2) | |
| Seat belt | 73 (47.1) | 36 (54.5) | 37 (41.6) | 0.24 |
| Airbag | 10 (6.5) | 6 (9.1) | 4 (4.5) | 0.29 |
| ED systolic BP | 128±22 | 128.7±22.8 | 126.7±20.8 | 0.53 |
| ED diastolic BP | 79±15 | 81.3±16.8 | 76.6±13.7 | 0.03 |
| ED HR | 93.4±19 | 89.9±18.4 | 96.2±19.5 | 0.01 |
| ED GCS | 13.4±3.9 | 13.6±3.6 | 13.2±3.2 | 0.54 |
| Chest AIS | 2.56±0.6 | 2.2±0.5 | 2.8±0.6 | 0.001 |
| ISS | 16±9 | 13±10 | 17±8 | 0.001 |
| Echocardiography, n (%) | 33 (16.0) | 9 (10.3) | 24 (20.2) | 0.05 |
| Troponin positive, n (%) | 46 (35.1) | 19 (30.6) | 27 (39.1) | 0.31 |
GCS: Glasgow Coma Scale, AIS: Abbreviated Injury Severity, ISS: Injury severity scoring, HR: Heart rate, BP: Blood pressure, ATV: All-Terrain vehicle, ED: Emergency department
Comparison of thoracic and extrathoracic injuries
| Overall (%) | No rib fracture (%) | With rib fracture (%) | ||
|---|---|---|---|---|
| Vertebral fracture | ||||
| Cervical fracture | 12 (5.7) | 4 (3.3) | 8 (6.7) | 0.44 |
| Thoracic fracture | 30 (14.2) | 11 (11.8) | 19 (16.0) | 0.39 |
| Lumbar fracture | 4 (1.9) | 0 (0.0) | 4 (3.4) | 0.07 |
| Retrosternal hematoma | 31 (14.6) | 13 (14.0) | 18 (15.1) | 0.81 |
| Lung contusion | 69 (32.5) | 18 (19.4) | 51 (42.9) | 0.001 |
| Hemothorax | 22 (10.4) | 3 (3.2) | 19 (16.0) | 0.003 |
| Right | 13 (59.1) | 2 (66.7) | 11 (57.9) | 0.53 for all |
| Left | 4 (18.2) | 1 (33.3) | 3 (15.8) | |
| Bilateral | 5 (22.7) | 0 (0.0) | 5 (26.3) | |
| Pneumothorax | 45 (21.2) | 5 (5.4) | 40 (33.6) | 0.001 |
| Right | 19 (42.2) | 3 (60.0) | 16 (40.0) | 0.42 for all |
| Left | 16 (35.6) | 2 (40.0) | 14 (35.0) | |
| Bilateral | 10 (22.2) | 0 (0.0) | 10 (25.0) | |
| Hemopneumothorax | 18 (8.5) | 4 (4.3) | 14 (11.8) | 0.05 |
| Right | 5 (27.8) | 1 (25.0) | 4 (28.6) | 0.54 for all |
| Left | 10 (55.6) | 3 (75.0) | 7 (50.0) | |
| Bilateral | 3 (16.7) | 0 (0.0) | 3 (21.4) | |
| Associated injuries | ||||
| Head | 37 (17.5) | 18 (19.4) | 19 (16.0) | 0.51 |
| Spleen | 9 (4.2) | 1 (1.1) | 8 (6.7) | 0.04 |
| Liver | 19 (9.0) | 6 (6.5) | 13 (10.9) | 0.25 |
| Bowel | 8 (3.8) | 3 (3.2) | 5 (4.2) | 0.71 |
| Spine | 93 (43.9) | 34 (36.6) | 59 (49.6) | 0.05 |
Comparison of thoracic injuries and management in patients with and without rib fracture
| Overall (%) | No rib fracture (%) | With rib fracture (%) | ||
|---|---|---|---|---|
| Thoracic injuries | ||||
| Pericardial | 2 (0.9) | 2 (2.2) | 0 (0.0) | 0.10 |
| Thoracic aorta | 6 (2.8) | 1 (1.1) | 5 (4.2) | 0.17 |
| Site of sternal fracture* | ||||
| Manubrium | 72 (35.1) | 24 (27.3) | 48 (41.0) | 0.04 |
| Upper sternum | 33 (16.1) | 17 (19.3) | 16 (13.7) | 0.27 |
| Middle sternum | 86 (42.0) | 44 (50.0) | 42 (35.9) | 0.04 |
| Lower sternum | 28 (13.7) | 11 (12.5) | 17 (14.5) | 0.67 |
| Clavicular fracture | 20 (9.4) | 1 (1.1) | 19 (16.0) | 0.001 |
| Right | 10 (50.0) | 0 (0.0) | 10 (52.6) | 0.37 for all |
| Left | 7 (35.0) | 1 (100) | 6 (31.6) | |
| Bilateral | 3 (15.0) | 0 (0.0) | 3 (15.8) | |
| Scapular fracture | 22 (10.4) | 3 (3.2) | 19 (16.0) | 0.003 |
| Right | 8 (36.4) | 2 (66.7) | 6 (31.6) | 0.42 for all |
| Left | 9 (40.9) | 1 (33.3) | 8 (42.1) | |
| Bilateral | 5 (22.7) | 0 (0.0) | 5 (26.3) | |
| Treatment (n=122) | ||||
| Conservative | 72 (59.0) | 30 (65.2) | 42 (55.3) | 0.03 for all |
| Orthopedic surgery | 24 (19.7) | 4 (8.7) | 20 (26.3) | |
| Spine fixation | 10 (8.2) | 5 (10.9) | 5 (6.6) | |
| Abdomen | 4 (3.3) | 1 (2.2) | 3 (3.9) | |
| Thoracic | 4 (3.3) | 0 (0.0) | 4 (5.3) | |
| Head | 2 (1.6) | 2 (4.3) | 0 (0.0) | |
| Maxillofacial | 1 (0.8) | 0 (0.0) | 1 (1.3) | |
| Superficial wound suture | 4 (3.3) | 3 (6.5) | 1 (1.3) | |
| Tracheostomy | 1 (0.8) | 1 (2.2) | 0 (0.0) |
*Overlap of sites of sternal fractures
Inhospital course and outcomes
| Overall | No rib fracture | With rib fracture | ||
|---|---|---|---|---|
| Intubation (%) | 57 (26.9) | 18 (19.4) | 39 (32.8) | 0.02 |
| Chest tube (%) | 20 (9.4) | 4 (4.3) | 16 (13.4) | 0.02 |
| Thoracotomy (%) | 4 (1.9) | 1 (1.1) | 3 (2.5) | 0.44 |
| Blood transfusion (%) | 50 (23.6) | 16 (17.2) | 34 (28.6) | 0.05 |
| Blood units transfused | 6.5 (1-44) | 6 (1-22) | 7 (1-44) | 0.28 |
| ISS | 15.6±9.3 | 13.3±9.6 | 17.5±8.6 | 0.001 |
| Ventilator days | 6 (1-43) | 5 (1-43) | 6 (1-29) | 0.91 |
| ICU LOS | 7.5 (1-58) | 6 (1-44) | 8 (1-58) | 0.91 |
| Hospital LOS | 5 (1-145) | 3 (1-90) | 7 (1-145) | 0.008 |
| Cardiac arrest | 10 (4.7) | 3 (3.2) | 7 (5.9) | 0.36 |
| Paraplegia (%) | 2 (0.9) | 1 (1.1) | 1 (0.8) | 0.86 |
| Mortality (%) | 9 (4.2) | 3 (3.2) | 6 (5.0) | 0.51 |
| Follow-up days | 209.1 (1-2621) | 134 (1-2573) | 235 (1-2621) | 0.28 |
ICU: Intensive care unit, LOS: Length of stay, ISS: Injury Severity Score